WolverHeme Happy Hour
de Bernard Marini, Anthony Perissinotti, et al.
Episode 49.5: R-CHOP and Chill - the Coolest Therapies at the Front…
À propos de ce podcast
Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!
Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
Épisodes
Les 20 épisodes les plus récents sur 51
- Episode 49.5: R-CHOP and Chill - the Coolest Therapies at the Front of our Minds · 58 min · Saison 1 Épisode 49In this episode, Bernie and Anthony team up with lymphoma experts Dr. Jon Weiss, Dr. James Davis, Dr. Eugene Przespolewski, and Dr. Aaron "Papa Heme" Goodman to discuss the…
- VAR Review with Dr. Bixby: Reversing the Call on MPAL · 1 h 6 min · Saison 1 Épisode 49In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage…
- Bispecifics ate CAR-T's lunch: a multiple myeloma debate · 56 min · Saison 1 Épisode 48In this episode, Bernie and Anthony are joined by Myeloma Man Manni Mohyuddin, MD to discuss the debate surrounding the treatment of first relapse in multiple myeloma. Should we…
- Episode 47: Cult-Like Thinking in BMT · 45 min · Saison 1 Épisode 47“However much we flatter ourselves about our individual rationality, a good story, no matter how analytically deficient, lingers in the mind, resonates emotionally, and persuades…
- Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology · 1 h 1 min · Saison 1 Épisode 46In this special video episode, Bernie and Anthony moderate a Common Sense Oncology discussion of key trials from ASH 2025! We are joined by special guest experts from across the…
- HLH: From Chaos to Clarity... and Back to Chaos! · 1 h 4 min · Saison 1 Épisode 45In this episode, Anthony and Bernie are joined by a panel of experts to discuss (and debate) everyone's favorite (or most feared) hematology topic - hemophagocytic…
- An Exercise in Uncertainty with Jonathan Gluck · 46 min · Saison 1 Épisode 44Anthony and Bernie are joined by special guest Jonathan Gluck, award-winning journalist and author of "An Exercise in Uncertainty: A Memoir of Illness and Hope" for a powerful…
- ASH Leukemia Review: the more we learn, the less we know! · 1 h 23 min · Saison 1 Épisode 43In this episode, Anthony and Bernie are joined by special guest, Dr. Justin Kaner from Weill Cornell Medicine, to discuss some of the most interesting ASH abstracts in leukemia…
- RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy · 41 min · Saison 1 Épisode 42Anthony and Bernie discuss the PARADIGM study that was presented at the plenary session of ASH 2025 and whether results should change our practice…
- MajesTEC-3 and ASH 2025: Let's get "TEC"nical · 1 h 9 min · Saison 1 Épisode 41In this study, Bernie and Anthony are joined by the majestic myeloma man Manni Mohyuddin to discuss key ASH abstracts in myeloma, including the results of the MajesTEC-3 study!
- Episode 40: Coffee and Community Hematology · 51 min · Saison 1 Épisode 40In this episode, Anthony and Bernie discuss the important role of community hematology. We discuss innovative research models, partnerships between community and academic…
- Chill For 5: The Febrile Neutropenia Survival Guide · 49 min · Saison 1 Épisode 39In this episode, Bernie and Anthony review the optimal management of febrile neutropenia! We talk about some historical data, optimal patient workup, proper selection of…
- Episode 38: Prophy and Pints! · 50 min · Saison 1 Épisode 37We're back after a summer break! In this episode, Anthony and Bernie review the optimal approach to antimicrobial prophylaxis in hematology patients. How do you best choose…
- Episode 37: Spilling Drinks over Cytarabine Dosing · 59 min · Saison 1 Épisode 37In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your…
- Episode 36: ODAC - Our Decisions Are Confusing · 43 min · Saison 1 Épisode 36In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on…
- CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined · 1 h 10 min · Saison 1 Épisode 35This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical…
- Dex and the Cytokine City: Managing CRS with Bispecifics · 60 min · Saison 1 Épisode 34In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to…
- LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML · 1 h 4 min · Saison 1 Épisode 33In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be…
- Episode 32: Navigating a BlinatumoMAD World · 1 h 6 min · Saison 1 Épisode 32In this episode, Anthony and Bernie are joined by two special guests to discuss recent updates to the use of blinatumomab in both adult and pediatric acute lymphoblastic leukemia…
- The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma · 49 min · Saison 1 Épisode 31AQUILA is a constellation shaped like an eagle, and also a hotly debated myeloma trial of daratumumab in smoldering multiple myeloma. In this episode, Bernie and Anthony are…







